Conclusion: In clinical trials of patients with type 2 diabetes mellitus, vildagliptin has been shown to reduce HbA 1c, fasting plasma glucose levels, prandial ... of inhaled insulin, none of ...

Clinical Diabetes found that people with type 1 diabetes can achieve positive results with new diabetes technology when trained by a primary care provider or through telehealth. Researchers from the ...

In patients with Type 2 diabetes mellitus (T2DM ... This initial surge in insulin is important for effective postprandial suppression of hepatic glucose production. Failure to suppress endogenous ...

Sulphonylureas and the glinides sensitize pancreatic β-cells to produce insulin. Both also cause ... compounds principally used to reduce post-prandial glucose surge. The glucose surge can ...

Noninferiority of URLi versus insulin lispro was shown in change of HbA1c from baseline to week 26. (b) LSM post-prandial glucose excursions at weeks 26 during mixed-meal tolerance tests.